Thursday's results marked the fifth consecutive quarter in which Rite Aid increased its same-store sales. And at the rate it's currently going, there's a good chance the country's third-largest retail pharmacy chain soon could become profitable, even though it expected to post losses in 2013, albeit even smaller losses than in 2012.
One of the highlights for Rite Aid’s business has been Wellness+, its loyalty card program that has played a major role in driving growth in the company’s comps, as well as attracting new and more loyal customers.
Despite running fewer stores, Rite Aid grew its sales and narrowed its losses during the fourth quarter and fiscal year 2012, thanks to a boost in its loyalty card program membership, a longer fiscal year and the continuing dispute between Walgreens and Express Scripts.
You can't uncrack an egg. That's the preliminary reply Express Scripts gave to the district court hearing the case filed by the National Association of Chain Drug Stores and the National Community Pharmacist Association to block the merger between Express Scripts and Medco.
Bainbridge & Knight on Tuesday announced the introduction of Lichi Super Fruit Super Probiotic, formulated with three strains of probiotic bacteria — Bifidobacterium lactis B1-04, BioOptima Saccharomyces boulardii and Lactospore.
Walgreens might be willing to acquire Rite Aid if it can't settle an ongoing contractual dispute with one of the country's largest pharmacy benefit managers, Walgreens' former CEO said in a conference call with investors Monday.
A miniature version of the spike in stock market activity that followed speculation about the prospects of a Walgreens-Rite Aid merger happened on Drug Store News' website as a quick writeup about the potential deal became the most-read story on the site. But for all the buzz that Credit Suisse analyst Edward Kelly created with his report, a Walgreens-Rite Aid merger appears pretty unlikely on closer inspection.